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Abstract
· AIM: To investigate whether the enhanced green
fluorescent protein (EGFP) reporter gene could be
transferred into human trabecular meshwork (HTM) cells
by a HIV-based lentivirus both and .
·METHODS: The HIV-based lentivirus that contains an
EF1 -琢 promoter driving EGFP expression cassette was
constructed following the standard molecular cloning
methods. The cultured HTM cells were transduced at a
range of multiplicity of infection (MOI) with HIV -based
lentivirus. EGFP positive cell populations were detected
by flow cytometry. Human anterior eye segments were
cultured with perfusion culture system and transfected
by HIV -based lentivirus with a 1 伊108 transducing unit
(TU) virus in perfusion liquid. The intraocular pressure
was recorded every 8h for 21d. The expression of EGFP
in the anterior segment of the human eye was detected
by fluorescence microscopy. Furthermore, the
distribution of EGFP expression was confirmed by anti-
EGFP immunohistochemical staining.
·RESULTS: The HIV-based lentivirus which contains an
EF1 -琢 promoter driving EGFP expression cassette was
constructed successfully. After HTM cells were
transduced with HIV-based lentivirus containing EGFP
, the ratio of EGFP positive cells to the total cell
number reached 92.3% , with the MOI of 15. After the
lentivirus containing EGFP were used to transduce
human anterior eye segments, the EGFP could be
directly detected by fluorescence microscopy .
Immunohistochemistry staining revealed that 88.19%
EGFP -positive trabecular meshwork (TM) cells were
observed in the human anterior segment. Nevertheless,
the intraocular pressure in the lentivirus -transduced
group kept constant when compared with control group
( >0.05).
· CONCLUSION: EGFP gene could be efficiently
transferred into HTM cells both and by
using HIV-based lentivirus.
·KEYWORDS: gene transfer; trabecular meshwork; HIV-
based lentivirus; glaucoma
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INTRODUCTION
G laucoma is the leading cause of irreversible blindnessworldwide [1] and elevated intraocular pressure (IOP) is
its major risk factor which appears to result from increased
trabecular meshwork (TM) outflow resistance. Clinically,
surgical or pharmacological treatment targeting TM could
lower elevated IOP [2]. Hence, TM has been considered as a
promising therapeutic target for the treatment of glaucoma[3].
Several studies have identified candidate genes that might
have a role in the pathogenesis of glaucoma [4]. These studies
suggest the possibility of using genetically modified TM cells
to treat glaucomatous IOP dysregulation. However, although
TM cells are highly metabolically active, they appear to
undergo a limited number of cellular division . Only
less than 0.5% of total TM cells have been estimated to be
mitotically active at any one time [5]. The challenge therefore,
is how to efficiently transfer the therapeutic gene to TM cells.
HIV-based lentivirus have the ability to transduce a broad
range of cell types efficiently, including non-dividing,
senescent and terminally differentiated cells [6]. In addition,
HIV-based lentivirus can integrate into the host cell genome
resulting in stable long-term transgene expression. In ocular
tissues, HIV-based lentivirus has been shown to have a
mediating effect and sustained transgene expression in uvea,
corneal endothelial cells, retinal pigment cells and
photoreceptors [7,8]. Loewen [9] used the HIV-based
lentivirus encoding 茁-galactosidase gene to transduce the
human anterior segment of the eye. However, the
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茁-galactosidase gene cannot be detected in living cells.
Therefore, the capability of monitoring enhanced green
fluorescent protein (EGFP) gene expression is an
advantage for establishing gene delivery approaches. In the
present study, we investigated whether HIV-based lentivirus
can be used to quantify transgene expression in the human
TM (HTM) cells and . In addition, we also
examined the IOP in cultured human anterior segments
transfected with HIV-based lentivirus, since the effect of
HIV-based lentivirus on IOP has never been fully assessed in
previous studies.
MATERIALS AND METHODS
Plasmids and Human Eye Anterior Segment Plasmids
pWPLXd, pMD2G, psPAX2 were generously supplied by
Tronolab lab. Human embryonic kidney 293T cells (HEK
293T cells) were provided by Prof. Jian-Feng Zhou who
works in the Department of Hematology of Tongji Hospital.
Plasmid pIRES2-EGFP and HeLa cells were kept in our lab.
Human cadaveric eyes (ages, 16-80y) without glaucoma,
uveitis, and other ophthalmic diseases were obtained less
than 24h postmortem from the Red Cross Eye Bank of
Wuhan (Wuhan, Hubei Province, China). Human donor
tissue protocols were approved by the University Institutional
Review Board of Huazhong University of Science and
Technology. Eight pairs of donor eyes were obtained and
used according to the provisions of the Declaration of
Helsinki for research involving human tissue.
Reagent Endonuclease BamHI, and EcoRI were purchased
from TaKaRa (Japan). Polymerase chain reaction (PCR)
reaction kit and T4 DNA ligase were provided by Fermantas
(Lithuania). LipofectamineTM 2000 was acquired from
Invitrogen (American) and fetal calf serum and Dulbecco's
modified eagle medium (DMEM) were bought from GIBICO
(American). Penicillin, streptomycin, amphotericin B and
gentamicin were obtained from Sigma-Aldrich (American).
The DNA primer was synthesized by Invitrogen (Shanghai,
China). The following primary antibodies were used in this
study: anti-fibronetion (FN) and anti-laminin (LN) (Santa
cruz, American), anti-neuron specific enolase (NSE) and
anti-factor VIII-related antigen (Chemicon, American),
anti-EGFP (Abcam, American). Human eye anterior segment
perfusion culture system was provided by Pang, I.H. (Alcon
Research, Ltd., Fort Worth, TX, USA). The perfusion pump
was manufactured by B. Braun (German) and the sensitive
pressure transducer was made by the Edwards Lifesciences,
LLC (Irive, CA, USA).
Plasmid Construction The EGFP reporter gene was
amplified from plasmid pIRES2-EGFP by DNA primer
which contains BamHI and EcoRI digestion site. The primer
sequences are as following: 5'-CCGGATCCGGGA
CGTGGTTTTCCTTTG-3', 5'-GCGAATTCCCTCTACAAA
TGTGGTATGGC-3'. The PCR product was digested by
BamHI and EcoRI and harvested from agarose
electrophoresis, then cloned to plasmid pWPXLd (which
already contains EF1-琢 promoter) based on the standard
protocol for (fifth edition, published by
Cold Spring Harbor Laboratory Press). The recombinant
plasmid containing EF1-琢 promoter driving EGFP expression
cassette was confirmed by restrictive enzyme digestion and
sequencing.
Preparation of HIV -based Lentivirus and
Determination of Viral Titer HIV-based lentiviral
particles were generated according to the protocols
previously described [10]. Briefly, HEK 293T cells were
transfected with 6 滋g of pMD2G envelope plasmid, 15 滋g of
psPAX2 packaging plasmid (pMD2G, psPAX2; Tronolab),
and 20 滋g of the HIV-based lentiviral transfer vector
pWPXLd-EGFP. Vector particles were collected from the
conditioned medium 48h post transfection. The virus-
containing supernatants were collected 48h after transfection,
filtered through 0.45 mm pore size Millipore filters,
concentrated by passage through Centricon-plus columns
(Millipore, Billerica, MA, USA), and kept at -80℃ until use.
Vector titers were determined by quantitative PCR on HeLa
cells as described previously [10]. In brief, 5伊104 HeLa cells
were transduced with serial dilutions of HIV-based lentiviral
preparations in the presence of polybrene (4-8 mg/mL;
Sigma-Aldrich, St. Louis, MO, USA). Five days later,
genomic DNA was extracted with a DNeasy kit according to
the manufacturer's protocol (Qiagen, Valencia, CA, USA).
Real-time PCR was performed with an ABI PRISM 7000
sequence detector (Applied Biosystems, Foster City, CA,
USA) with primers and probe corresponding to the truncated
gag gene present in all vectors. Serial dilutions of pWPXLd
plasmid DNA were used to establish standard curves.
Culture of Human Trabecular Meshwork Cells The
culture of HTM cells was briefly described as follows:
Trabecular specimens were obtained less than 24h
postmortem. The TM tissue was microdissected under an
operating microscope. Explants of dissected trabecular tissue
were placed in DMEM/F12 with 10% fetal bovine serum
(FBS). After migrating from the primary explants and
seeding on plate, the TM tissue explants were removed.
Passage of TM cells was performed at a ratio of 1:4 using
0.1% trypsin when they reached 90% confluence.
Identification of HTM cell was confirmed by
immunochemistry staining of FN, LN, NSE and Factor Ⅷ
relative antigen (FⅧRag).
Infection of Human Trabecular Meshwork Cells with
HIV-based Lentivirus and Assessment of Transduction
Third generation of cultured HTM cells, 1伊105 cells per well,
were seeded in 6-well plates and then randomly divided into
6 groups ( =5). The next day, cells were transduced with
HIV-based lentivirus with a gradient dilution of multiplicity
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of infection (MOI)=0, 1, 5, 10, 15, 20 respectively. When
EGFP could be detected by fluorescence microscopy, cells
were harvested for flow cytometry analysis. The percentage
of EGFP-positive cells was calculated by using Guava
Express Plus analysis on a Guava Easy CyteTM flow cytometer
(Guava Technologies, Millipore, Billerica, MA, USA).
Culture of Anterior Segment of Human Eye and the
Monitoring of the Intraocular Pressure The procedures
for the perfusion of the human eye anterior segment,
according to the protocol previous described [11], are as
follows: eyes were dissected along the equator. Iris, lens,
ciliary body and vitreous were removed. The anterior
segment of the eye was clamped in a custom-made Plexiglas
culture dish and sealed in place with a Plexiglas O-ring. The
anterior segments of the eye were perfused with Dulbecco's
modified Eagle's medium containing antibiotics (penicillin:
10,000 U/100 mL solution, streptomycin: 10 mg, amphotericin
B: 25 mg, and gentamicin: 17 mg, in 100 mL medium) at the
constant flow rates (2.5 滋L/min) using a perfusion pump at
37℃ in 5% CO2 atmosphere. IOP of the anterior segments
was continuously monitored by a second cannula attached to
a sensitive pressure transducer. The IOP was recorded every
8h and data were averaged daily.
Infection of the Anterior Segment of the Human Eye
with HIV -based Lentivirus Containing the Enhanced
Green Fluorescent Protein The anterior segments of eye
were equilibrated for 3d before being infected with the
HIV-based lentivirus containing EGFP. Those did not reach a
stable baseline of IOP were discarded. For eachpair, one eye
was treated with HIV-based lentiviral vector containing
EGFP and the other one was perfused with a null-lentiviral
virus medium. In total, 108 transducing units (TU) HIV-based
lentiviral particles were applied as a bolus to the perfusion
chambers (indicated by time point 0) and pressure was
monitored for 21d. On day 21 (the end of the experiment),
anterior segments were removed from the perfusion
chambers for fluorescence microscopy analysis (data
obtained from three samples collected for each group) and
then fixed with 4% paraformaldehyde. Tissue sections were
prepared for anti-EGFP staining by using streptavidin
biotinperoxidase complex (SABC) methods. To measure
transduction efficiency of lentivirus, each anterior segment
was divided into four quadrants. A section from each
quadrant was taken for anti-EGFP staining. Positive cell
bodies and stained nuclei were manually counted and the
percentage of EGFP expressing cells versus stained nuclei
was calculated.
Statistical Analysis Measurement data are presented as
mean依S.E.M (standard error of mean). For EGFP
positive ratio data analysis, one-way ANOVA was used. For
EGFP positive ratio data analysis, -test was used.
For IOP data, Repeated-measure ANOVA analysis was used
for within group and -test analysis for between groups. <
0.05 was considered statistically significant.
RESULTS
Successful Construction of HIV -based Lentivirus
Containing the Enhanced Green Fluorescent Protein
Gene After vector pWPXLd/EGFP was constructed, its
sequence was confirmed by restriction enzyme digestion and
nucleotide sequencing analysis. After double endonuclease
digestion of the vector pWPXLd/EGFP, the agarose
electrophoresis results showed that it contains a fragment
which is about 800 bp in length and similar to the size of its
PCR product, whereas the null-vector control does not.
Sequence testing confirmed that plasmid pWPXLd/EGFP
contains the EGFP sequence without DNA mutation. When
pWPXLd/EGFP was used for HIV-based lentivirus packing
according to a standard protocol, all the vectors achieved a
titration of 107 TU/mL before concentration and
approximately 109 TU/mL after concentration.
Highly Purified Human Trabecular Meshwork Cells
Were Cultured HTM cells of the third
generation were identified by immunochemistry staining.
These HTM cells showed morphological diversity: fusiform,
triangle and irregular shape. There were many processes on
body cells that were rich in cytoplasm and usually there were
a few pigment granules found inside. The nucleus was
circular or oval in shape. Further immunochemistry staining
revealed that these cells were positive in anti-LN (Figure 1B),
anti-NSE (Figure 1C), anti-FN (Figure 1D) staining, but
negative in anti- FⅧRag staining (Figure 1A).
HIV -based Lentivirus Efficiently Transduced Human
Trabecular Meshwork Cell After HTM cells
were transfected with HIV-based lentiviral vectors for five
days, EGFP could be detected by fluorescence microscopy
(Figure 2D). Flow cytometric analysis of the HTM cells
showed that about 92.3% cells are EGFP positive when MOI
is 15 (Figure 2G, 2H), which is the highest ratio of EGFP
positive HTM cells obtained. The ratio of EGFP positive
HTM cells between an MOI of 15 and 20 is not statistically
significant, indicating that more viral particles will not
increase the transfection ratio in a positive manner.
High Efficiency of HIV -based Lentivirus Transduced
Human Trabecular Meshwork Cell After
cultured anterior segments of the human eye were perfused
with HIV-based lentivirus for 21d, EGFP could be detected
directly by fluoresce microscope (Figure 3A, 3C). Positive
cells were mainly localized within TM and some in cornea
tissue (Figure 3C). Further immunohistochemistry staining
confirmed that EGFP positive staining mainly exist in TM,
schlemm's canal (Figure 3E) with some in corneal
endothelium (data is not shown). Cell count results showed
that (88.19依7.13) % TM cells were EGFP positive.
Intraocular Pressure Kept Constant When Cultured
Anterior Segments of Human Eye Were Transfected
With HIV-based Lentivirus After equilibration for 3d, the
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Figure 2 The efficiency of HIV-based lentivirus transducing Cultured HTM cells Cultured HTM cells were transduced with
lentivirus containing EGFP gene. Five days later, EGFP could be detected in the transfected cells (A and B are null-vector controls for C and
D, respectively; A and C are brightfield images, while B and D are fluorescent images; scale bar=50 滋m). The ratios of EGFP positive cells
were detected by flow cytometric analysis. Health HTM cells were gated based on forward scatter (FSC) and side scatter (SSC).
Representative flow cytometry plots of E and F are from those cells transduced by null-vector controls, respectively the G and H are from
those cells transduced by lentivirus containing EGFP with MOI of 15. E and G show cell population of interested, while F and H show EGFP
positive cell ratio. After HTM cells were transfected with HIV-based lentiviral vector containing EGFP at a different range of MOI, the ratio
of EGFP positive cells was calculated based on the following formula: (EGFP positive cells/HTM total cells)伊100%, as illustrated in Figure
2I. Data are shown as mean 依SD ( = 3) of three independent experiments.
Figure 1 Identification of HTM cells by immunochemistry staining HTM cells of third generation were fixed and used for
immunochemistry staining (SABC methods). Results showed that anti- FⅧ Rag was negative in cultured HTM cells (1A), and anti-LN (1B),
anti-NSE(1C), anti-FN (1D) were positive. Scale bar=50 滋m.
IOP of human anterior segments reached a stable baseline.
Right after lentivirus perfusion to anterior segment of the eye,
the IOP increased slightly. However, on day 2 the IOP
returned to baseline levels by day 3. Continual IOP
monitoring showed that the IOP kept constant when
compared with the baseline ( >0.05, repeated-measure
ANOVA, Figure 4) and there was also no statistical difference
when compared with control group ( >0.05, -test, Figure 4).
DISCUSSION
Reducing IOP is the most important treatment for glaucoma
and TM plays a pivotal role in the aqueous humor drainage
from the anterior chamber. Gene therapy that targets the TM
is a promising therapeutic strategy in lowering IOP. How to
efficiently and safely transfer the therapeutic gene to TM
927
Figure 3 Genetic modification of HTM cells in an model of cultured anterior segment of human eye Cultured anterior
segments of the human eye were transfected with HIV-based lentivirus which was delivered by perfusion system. Twenty-one days later,
EGFP expression could be detected by fluorescence microscopy in transfected cells (A: Brightfield image, C: Fluorescent image, scale
bar=500 滋m), but not in control group (B: Brightfield image, D: Fluorescent image; scale bar=500 滋m). Further immunochemistry study
showed that EGFP was expressed both in TM and Schlemm's canal (E for EGFP contained HIV-based lentivirus, F for control virus, scale
bar=100 滋m). EGFP positive cell ratio were calculated by counting positive cells and the total cell nucleus (G for positive cell ratio, -test,
<0.01).
Figure 4 IOP of cultured anterior segment of the human eye receiving HIV-based lentivirus When cultured anterior segments of the
human eye (Figure 4A, 4B) were transfected with HIV-based lentivirus, IOP was recorded every 8h. Figure 4C showed that IOP did not
change when compared with the baseline (repeated-measure ANOVA, >0.05) and control group ( -test, >0.05).
cells is the major obstacle that needs to be overcome. Here
we have successfully transferred an exogenous gene to HTM
cells both and using HIV-based lentivirus
encoding EGFP gene. Furthermore, the expression of EGFP
transferred by HIV-based lentivirus in HTM cells does not
change IOP in an model.
Several studies have tried to transfer an exogenous gene to
HTM cells both and by various gene therapy
vectors including adenovirus [12], adeno-associated virus
(AAV)[13, 14], lentivirus[15, 16], and non-viral vectors[14]. Lentivirus
are considered some of the most promising vehicles to
effectively genetically modify cells for basic research and
gene therapy approaches [17]. There are many types of
engineered lentivirus such as, HIV, feline immunodeficiency
virus (FIV), equine infectious anemia virus (EIAV), Simian
immunodeficiency virus (SIV) and bovine immunodeficiency
virus (BIV). EIAV vectors were shown to transduce mouse
TM [18]. FIV vectors have already been tested in rodent, cat
and no-human primates and the human model of the anterior
chamber[15, 19]. Furthermore, HIV-based lentivirus has been the
most extensively studied vector and it has been shown that it
can efficiently transfer an exogenous gene into many eye
tissues[7].
Our results demonstrated that an HIV-based lentivirus could
efficiently transfer an exogenous gene to HTM cells both
and . For an study, it has shown very
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high transducing efficiency as 92.3% HTM cells were
transfected by HIV-based lentivirus. In studies, the
EGFP gene is expressed in about 88.16% TM cells of human
anterior segment after transduction by HIV-based lentivirus.
Not only were we able to detect high levels of EGFP gene
expression in HTM cells of the anterior segment, but we also
found that the IOP kept constant when transfected with
lentivirus. To some extent, this indicated that HIV-based
lentivirus could safely be used for HTM cells gene transfer.
Furthermore, in this study, we directly monitored green
fluorescent of EGFP transgene expression in HTM
rather than in a fixed dye condition. It is therefore, possible to
observe gene transfer and expression in future gene therapy
. In this study, the housekeeping EF1-琢 promoter
robustly drove the expression of EGFP gene, but it did not
direct strictly HTM cell-specific expression of foreign genes,
as EFGP fluorescence could be detected in some corneal
endothelium cells. For specific targeting, additional strategies
such as addressing tissue specific promoter matrix Gla
protein (MGP) promoter may be useful in this regard[20].
Since glaucoma is a chronic disease, IOP requires long-term
control. Lentivirus may be a good choice because it could
stably integrate as an obligate part of the transduction process
and result in long-lasting expression. This study has shown
that gene transfer to TM can be achieved by the
administration of lentivirus circulating into the anterior
chamber. Therefore, the delivery of appropriate therapeutic
genes to the TM using HIV-based lentiviral systems could
reduce the IOP, providing hope for a potential treatment of
glaucoma - an irreversible blindness affecting millions of
people worldwide.
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